| __timestamp | Ligand Pharmaceuticals Incorporated | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 64538000 | 122045000 |
| Thursday, January 1, 2015 | 71914000 | 144427000 |
| Friday, January 1, 2016 | 108973000 | 215003000 |
| Sunday, January 1, 2017 | 141102000 | 302238000 |
| Monday, January 1, 2018 | 251453000 | 408897000 |
| Tuesday, January 1, 2019 | 120282000 | 392755000 |
| Wednesday, January 1, 2020 | 186419000 | 520397000 |
| Friday, January 1, 2021 | 277133000 | 579775000 |
| Saturday, January 1, 2022 | 196245000 | 667238000 |
| Sunday, January 1, 2023 | 131314000 | 607521000 |
Unlocking the unknown
In the competitive landscape of pharmaceuticals, Ligand Pharmaceuticals Incorporated and Supernus Pharmaceuticals, Inc. have showcased intriguing revenue trajectories over the past decade. From 2014 to 2023, Supernus Pharmaceuticals consistently outperformed Ligand, with revenues peaking at approximately 667 million in 2022, marking a staggering 447% increase from 2014. In contrast, Ligand's revenue growth was more modest, peaking at around 277 million in 2021, a 329% increase from its 2014 figures.
The data reveals a pivotal year in 2018 when Supernus's revenue surged past the 400 million mark, while Ligand experienced a significant leap to 251 million. Despite Ligand's impressive growth in 2021, Supernus maintained its lead, highlighting its robust market strategy. As we look to the future, these trends underscore the dynamic nature of the pharmaceutical industry and the importance of strategic innovation.
Regeneron Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis
Takeda Pharmaceutical Company Limited vs Ligand Pharmaceuticals Incorporated: Examining Key Revenue Metrics
Genmab A/S vs Supernus Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Bio-Techne Corporation and Supernus Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Walgreens Boots Alliance, Inc. or Ligand Pharmaceuticals Incorporated: Who Leads in Yearly Revenue?
Revenue Showdown: Walgreens Boots Alliance, Inc. vs Supernus Pharmaceuticals, Inc.
Exelixis, Inc. and Supernus Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Ascendis Pharma A/S and Ligand Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis
Revenue Insights: Alkermes plc and Supernus Pharmaceuticals, Inc. Performance Compared
Revenue Showdown: Veracyte, Inc. vs Supernus Pharmaceuticals, Inc.
Comparing Revenue Performance: Ligand Pharmaceuticals Incorporated or Novavax, Inc.?
Ligand Pharmaceuticals Incorporated and MiMedx Group, Inc.: A Comprehensive Revenue Analysis